Fever clearance time · Children with cancer who develop a low‐risk febrile neutropaenic event
1 finding from 1 review
Urological symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Bother (HRQoLc at 12 months) · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
TUR syndrome · men with lower urinary tract symptoms secondary to benign prostatic obstruction
BTURP probably leads to lower TUR syndrome compared with MTURP (moderate certainty).
1 finding from 1 review
Urinary incontinence late postnatal period (> 6‐12 months) · men with lower urinary tract symptoms secondary to benign prostatic obstruction
BTURP showed no clear difference in urinary incontinence at 12 months compared with MTURP (low certainty).
1 finding from 1 review
Blood transfusion · men with lower urinary tract symptoms secondary to benign prostatic obstruction
BTURP probably leads to lower blood transfusion compared with MTURP (moderate certainty).
1 finding from 1 review
Re‐TURP · men with lower urinary tract symptoms secondary to benign prostatic obstruction
BTURP showed no clear difference in re‐TURP compared with MTURP (low certainty).
1 finding from 1 review
Erectile function · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Disease activity · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
1 finding from 1 review
Proportion participants that switched to another biologic due to loss of response ‐ not measured · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with minimal radiographic progression · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
Anti‐TNF discontinuation leads to higher proportion participants with minimal radiographic progression compared with anti‐TNF continuation (high certainty).
1 finding from 1 review
Function · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
1 finding from 1 review
Number of serious adverse events · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
It is very uncertain whether anti‐TNF discontinuation changes number of serious adverse events compared with anti‐TNF continuation (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
Anti‐TNF discontinuation showed no clear difference in withdrawals due to adverse events compared with anti‐TNF continuation (moderate certainty).
1 finding from 1 review
Disease activity · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
1 finding from 1 review
Maintenance of clinical remission · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
Anti‐TNF disease activity–guided dose tapering showed no clear difference in proportion of participants with persistent remission compared with anti‐TNF continuation (high certainty).
1 finding from 1 review
Proportion of participants switched to another biologic due to loss of response · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
Anti‐TNF disease activity–guided dose tapering showed no clear difference in proportion of participants switched to another biologic due to loss… compared with anti‐TNF continuation (low certainty).
1 finding from 1 review
Proportion of participants with minimal radiographic progression · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
Anti‐TNF disease activity–guided dose tapering showed no clear difference in proportion of participants with minimal radiographic progression compared with anti‐TNF continuation (low certainty).
1 finding from 1 review
Function · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
1 finding from 1 review
Maintenance of clinical remission · people with rheumatoid arthritis with low disease activity using a standard dose of anti‐TNF agents
Anti‐TNF dose reduction showed no clear difference in proportion of participants with persistent remission compared with anti‐TNF continuation (low certainty).
1 finding from 1 review